GENE ONLINE|News &
Opinion
Blog

2020-10-13| Asia-Pacific

ITRI and Gemseki Agreed on the Collaboration of Licensing Activities

by GeneOnline
Share To

Industrial Technology Research Institute (ITRI), the applied technology institution in Taiwan, has agreed with Gemseki Inc. (Gemseki) for the collaboration on licensing and partnering of ITRI’s drug candidates and technologies (“assets”). Under the agreement, Gemseki is conducting licensing and business development activities worldwide for ITRI’s assets. Gemseki supports to find strategic partners and helps negotiations for these assets.

Dr. Chii-Wann Lin, ITRI Vice President and General Director of Biomedical Technology and Device Research Laboratories, comments, “ITRI has a lot of good drug candidates and technologies, and we are looking for partners for these assets. Gemseki has built an innovative business model and shares our vision to make innovation happen in the life science industry. Its established global network is also appealing for us, aligning with our strategy of leveraging worldwide resources. With this collaboration, I believe ITRI can expedite the commercialization of our technologies and making contributions to the world.”

Mr. Hideyuki Hirama, President and CEO of Gemseki, comments, “It is a great honor to work with ITRI, a prestigious research institution in Taiwan. I am very impressed with ITRI’s R&D capability. Also, I am very fascinated by the leadership that Dr. Lin takes to bring more innovation. We will be seeking partnering opportunities for ITRI’s great assets by utilizing our global network. We are very excited to be able to contribute to the development of the life science industry in Taiwan.”

References

  1. https://www.gemseki.com/en/news/590

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
R&D
Taiwan Greenlights BMS, Ono’s Opdivo For Frontline Esophageal Cancer
2022-07-20
LATEST
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
AstraZeneca Thailand Wins Two ACES Awards 2022: “Industry Champions of the Year” and “Community Initiative”
2022-11-24
Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND
2022-11-24
Novartis Shifts Gear To Phase 3 For Anti-Malaria Drug
2022-11-24
Moving Past Animal Models with Better Data for Drug Discovery
2022-11-23
IonOpticks ushers in a new age of proteomics with Aurora Frontier
2022-11-23
Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human immune response
2022-11-23
EVENT
2022-12-01
BIOCHINA 2022
Online
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!